Fibrin Sealant Market to Grow with a CAGR of 6.88% through 2028
Emerging applications of fibrin sealant in
microsurgery and implant site flap closure and increasing demand for dental
surgeries are factors driving the Global Fibrin Sealant Market in the forecast
period 2024-2028.
According to TechSci Research report, “Fibrin
Sealant Market – Global Industry Size, Share, Trends, Competition Forecast
& Opportunities, 2028”, the Global Fibrin Sealant Market has valued at USD 1.23 billion in 2022 and is anticipated to project robust growth in the forecast
period with a CAGR of 6.88% through 2028.
Technological advancements have played a pivotal role
in shaping the global Fibrin Sealant market, transforming it into a vital
component of modern surgical practices. Fibrin sealants, also known as fibrin
glue or tissue adhesives, have benefited immensely from innovative
developments, making them more effective, versatile, and safer for a wide range
of medical applications.
One significant
technological advancement is the refinement of fibrin sealant formulations.
Traditional fibrin sealants consisted of two components, fibrinogen and
thrombin, mixed at the point of care. However, recent innovations have led to
the production of ready-to-use, one-component fibrin sealants. These pre-mixed
formulations eliminate the need for manual mixing, ensuring consistency and
reducing the risk of errors during surgery.
Moreover, the
incorporation of advanced biotechnology and recombinant DNA techniques has
enabled the development of more stable and potent fibrin sealants. These
next-generation sealants offer superior hemostatic properties and adhesive
strength, making them effective in various surgical scenarios, from
cardiovascular and orthopedic procedures to neurosurgery and ophthalmology.
Another notable
advancement is the integration of nanotechnology into fibrin sealant
development. Nanoparticles and nanofibers have been utilized to enhance the
mechanical properties, tissue adhesion, and drug-delivery capabilities of
fibrin sealants. This allows for precise control over the release of
therapeutic agents, such as growth factors or antimicrobial agents, during the
healing process.
Technological
progress has also expanded the application of fibrin sealants beyond surgical
hemostasis. They are now used in tissue engineering and regenerative medicine,
where they serve as bioactive scaffolds for cell growth and tissue repair. This
opens exciting possibilities for personalized medicine and the development of
tissue-engineered constructs for various medical needs.
Furthermore,
advancements in delivery systems have made the application of fibrin sealants
more precise and minimally invasive. Devices like laparoscopic applicators and
endoscopic delivery systems allow surgeons to apply fibrin sealants in a
controlled manner, reducing tissue trauma and postoperative complications.
In conclusion,
technological advancements have elevated fibrin sealants from simple hemostatic
agents to sophisticated tools that enhance surgical outcomes and promote tissue
regeneration. The global Fibrin Sealant market continues to benefit from these innovations,
offering healthcare professionals and patients alike safer and more effective
solutions in a wide range of medical specialties.
Browse over XX market data Figures spread
through XX Pages and an in-depth TOC on "Global Fibrin
Sealant Market”
The Global Fibrin Sealant Market is segmented into products,
end user, regional distribution, and company
Based on the Product,
the Liquid Form segment emerged as the dominant player in the global
market for Fibrin Sealant. The liquid segment is expected to maintain its
dominance in the fibrin glue market, primarily due to its superior procedural
outcomes compared to other patch forms. Liquid fibrin glue offers several
advantages, including rapid action and enhanced stability, which contribute to
its growing popularity.
Notably, liquid solutions can achieve hemostasis
within a remarkably short period, typically ranging from 3 to 4 minutes after
application. These qualities make liquid fibrin glue a preferred choice among
medical practitioners, further bolstering its prominence within the market.
The Asia-Pacific region is poised to experience robust
growth during the forecast period. The Asia-Pacific region is expected to
experience robust growth, attributed to the entry of new market players and the
implementation of strategic marketing policies. Additionally, the rapid
development of healthcare infrastructure in countries like China and India,
combined with increased healthcare expenditure in Japan and Australia, presents
significant growth opportunities in this region by 2026.
In North America, the market is poised for substantial
growth, driven by a rapid increase in surgical procedures and a strong emphasis
on the adoption of minimally invasive surgeries. Furthermore, the United
States, in particular, is witnessing a surge in the adoption of technology for
minimally invasive surgical procedures, further fueling market expansion in the
region.
In Latin America and the Middle East & Africa, the
market is set to grow due to an increasing number of healthcare facilities and
a rising volume of cardiac interventions. These factors are anticipated to
drive the expansion of the fibrin glue market in these regions, showcasing
their growing importance in the global healthcare landscape.
Major companies operating in Global Fibrin
Sealant Market are:
- Johnson and Johnson
- Baxter International Inc.
- Nordson Corporation (Nordson Medical)
- Corza Health Inc
- Becton Dickinson and Company
- CSL Behring LLC
- Grifols SA
- Shanghai RAAS Blood Products Co., Ltd.
- Vivostat A/S
- Hemarus Therapeutics Ltd.
Download
Free Sample Report
Customers can also request for 10%
free customization on this report
“The global Fibrin Sealant market has experienced
substantial growth in recent years, driven by various factors. Fibrin sealants,
also known as tissue glues or surgical adhesives, are biocompatible and
versatile medical products widely used in surgery to control bleeding and
promote tissue healing. This market has expanded due to the increasing number
of surgical procedures worldwide, including complex surgeries in areas like
cardiovascular, orthopedic, and gastrointestinal.
One of the key drivers of market growth is the growing
demand for minimally invasive surgical techniques, where fibrin sealants are
crucial in reducing complications and accelerating patient recovery.
Additionally, advancements in fibrin sealant formulations have improved their
effectiveness and safety profile, further boosting their adoption.
Furthermore, the aging global population has
contributed to the rise in surgical interventions, particularly in procedures
related to chronic diseases and degenerative conditions. The need for effective
hemostatic and tissue sealing agents in these surgeries has driven the demand
for fibrin sealants,” said Mr. Karan Chechi, Research Director with TechSci
Research, a research-based management consulting firm.
“Fibrin Sealant Market- Global Industry Size,
Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented by Product
(Liquid Form, Patch), By End User (Ambulatory Surgical Centers, Hospitals,
Specialty Clinics), By Region and
competition”, has evaluated the future growth potential of Global Fibrin Sealant
Market and provides statistics & information on market size, structure and
future market growth. The report intends to provide cutting-edge market
intelligence and help decision makers take sound investment decisions. Besides,
the report also identifies and analyzes the emerging trends along with
essential drivers, challenges, and opportunities in Global Fibrin Sealant
Market.
Contact
TechSci Research LLC
420 Lexington Avenue,
Suite 300, New York,
United States- 10170
M: +13322586602
Email: [email protected]
Website: https://www.techsciresearch.com